1. Zhu, Zhehui, Guo, Yuegui, Liu, Yun, Goel, Ajay, Liu, Chen-Ying. 2023. ELK4 Promotes Colorectal Cancer Progression by Activating the Neoangiogenic Factor LRG1 in a Noncanonical SP1/3-Dependent Manner. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 10, e2303378. doi:10.1002/advs.202303378. https://pubmed.ncbi.nlm.nih.gov/37786278/
2. Yang, Wenhan, Gao, Kaiping, Qian, Youhui, Zheng, Duo, Zhai, Rihong. 2022. A novel tRNA-derived fragment AS-tDR-007333 promotes the malignancy of NSCLC via the HSPB1/MED29 and ELK4/MED29 axes. In Journal of hematology & oncology, 15, 53. doi:10.1186/s13045-022-01270-y. https://pubmed.ncbi.nlm.nih.gov/35526007/
3. Yang, Haiming, Yuan, Ying, Yang, Ke, Wang, Ning, Li, Xiao. 2024. ELK4 ameliorates cognitive impairment and neuroinflammation induced by obstructive sleep apnea. In Brain research bulletin, 216, 111054. doi:10.1016/j.brainresbull.2024.111054. https://pubmed.ncbi.nlm.nih.gov/39173777/
4. Huang, Mengqi, Tabib, Tracy, Khanna, Dinesh, Domsic, Robyn, Lafyatis, Robert. 2024. Single-cell transcriptomes and chromatin accessibility of endothelial cells unravel transcription factors associated with dysregulated angiogenesis in systemic sclerosis. In Annals of the rheumatic diseases, 83, 1335-1344. doi:10.1136/ard-2023-225415. https://pubmed.ncbi.nlm.nih.gov/38754983/
5. Li, Haiyan, Chen, Zedong, Huang, Yuanjie, Chen, Chen, Cai, Limin. 2024. ELK4 targets CHMP6 to inhibit ferroptosis and enhance malignant properties of skin cutaneous melanoma cells. In Archives of dermatological research, 316, 634. doi:10.1007/s00403-024-03367-5. https://pubmed.ncbi.nlm.nih.gov/39305302/
智鼠故事 
